期刊
ACTA NEUROLOGICA SCANDINAVICA
卷 123, 期 2, 页码 117-121出版社
WILEY
DOI: 10.1111/j.1600-0404.2010.01352.x
关键词
apolipoprotein E; levodopa; levodopa-induced dyskinesias; Parkinson's disease; polymorphism
Objectives - To determine the relationship between apolipoprotein E (APOE) polymorphisms to the time to appearance of levodopa-induced dyskinesia (LID) in patients with Parkinson's disease. Methods - The APOE genotype of 155 consecutive patients treated with levodopa was determined and its effect on the time of onset of LID was examined using Cox regression model, controlling for gender, age of disease onset, time to initiation of levodopa treatment and history of smoking. Results - Two patients were homozygous for the APOE epsilon 2 allele, 7 had epsilon 2/epsilon 3, 1 had epsilon 2/epsilon 4, 130 had epsilon 3/epsilon 3, 12 had epsilon 3/epsilon 4 and 3 had epsilon 4/epsilon 4; LID appeared in 57.4% of the patients, appearing 4.1 +/- 3.5 years after the initiation of levodopa treatment. The survival curve for LID was not affected by the APOE genotype (P = 0.34). Conclusion - APOE polymorphisms were found not to be associated with either the occurrence or the time to development of LID.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据